The receptor tyrosine kinase Fms-like tyrosine kinase 3 (FLT3) is highly expressed in most patients with AML, and nearly 30% of them possess an internal tandem duplication (ITD) within the juxtamembrane domain that is associated with a poor outcome. The gene discussed is FLT3; the disease is acute myeloid leukemia.